Refractory Angina Manufacturers, Suppliers & Companies
-
Manufacturerbased in Santa Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc Reducer - Treatment of Refractory Angina and Tiara System
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ ...
CONTACT SUPPLIER -
Manufacturerbased in Wayne, PENNSYLVANIA (USA)
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...
Model XC001 - Investigational Gene Therapy for Refractory Angina - Enrolling Phase 1/2
XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or coronary ...
CONTACT SUPPLIER -
Manufacturerbased in Basking Ridge, NEW JERSEY (USA)
Caladrius is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing ...
Caladrius - Model CLBS14 - No-Option Refractory Disabling Angina (NORDA)
No-option refractory disabling angina (NORDA) describes patients who have severe and disabling angina, which persists despite revascularization (e.g. bypass surgery or stenting) and optimal medical ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you